IO Biotech Ownership 2024 | Who Owns IO Biotech Now?
Institutional Ownership
0.33%
Insider Ownership
0.24%
Retail Ownership
99.43%
Institutional Holders
3.00
IO Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIVO CAPITAL, LLC | 9.37% | 0.67% | 6,173,439 | - | - | 7,222,924 | Jun 30, 2024 |
NOVO HOLDINGS A/S | 6.72% | 0.30% | 4,429,449 | -658,809 | -12.95% | 5,182,455 | Jun 30, 2024 |
SAMSARA BIOCAPITAL, LLC | 5.53% | 0.89% | 3,640,015 | - | - | 4,258,818 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 3.55% | 0.14% | 2,341,107 | - | - | 2,739,095 | Jun 30, 2024 |
MARSHALL WACE, LLP | 3.20% | 0.00% | 2,105,262 | - | - | 2,463,156 | Jun 30, 2024 |
MORGAN STANLEY | 2.99% | 0.00% | 1,972,343 | -224,891 | -10.24% | 2,307,641 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 2.51% | 0.00% | 1,651,515 | -192,670 | -10.45% | 1,932,273 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 2.35% | 0.02% | 1,545,000 | -179,000 | -10.38% | 1,807,650 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.50% | 0.01% | 987,654 | - | - | 1,155,555 | Jun 30, 2024 |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.31% | 0.78% | 864,197 | - | - | 1,011,110 | Jun 30, 2024 |
LOGOS GLOBAL MANAGEMENT LP | 0.75% | 0.05% | 493,827 | - | - | 577,778 | Jun 30, 2024 |
FMR LLC | 0.48% | - | 314,600 | - | - | 368,082 | Jun 30, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.29% | 0.02% | 192,670 | 192,670 | 100.00% | 225,424 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 180,800 | 13,600 | 8.13% | 211,536 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 124,623 | - | - | 145,809 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 33,307 | - | - | 38,969 | Jun 30, 2024 |
XTX TOPCO LTD | 0.04% | 0.00% | 26,555 | 10,688 | 67.36% | 31,069 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 4,166 | 4,166 | 100.00% | 4,874 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 3,280 | 3,280 | 100.00% | 3,838 | Jun 30, 2024 |
STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -156,167 | -100.00% | - | Jun 30, 2024 |
IO Biotech's largest institutional shareholder is VIVO CAPITAL, LLC, holding 9.37% of the company's total share outstanding, currently valued at $7.22M. The top 10 institutional shareholders own together 39.02% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SAMSARA BIOCAPITAL, LLC | 5.53% | 0.89% | 3,640,015 | - | - | 4,258,818 | Jun 30, 2024 |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.31% | 0.78% | 864,197 | - | - | 1,011,110 | Jun 30, 2024 |
VIVO CAPITAL, LLC | 9.37% | 0.67% | 6,173,439 | - | - | 7,222,924 | Jun 30, 2024 |
NOVO HOLDINGS A/S | 6.72% | 0.30% | 4,429,449 | -658,809 | -12.95% | 5,182,455 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 3.55% | 0.14% | 2,341,107 | - | - | 2,739,095 | Jun 30, 2024 |
LOGOS GLOBAL MANAGEMENT LP | 0.75% | 0.05% | 493,827 | - | - | 577,778 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 2.35% | 0.02% | 1,545,000 | -179,000 | -10.38% | 1,807,650 | Jun 30, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.29% | 0.02% | 192,670 | 192,670 | 100.00% | 225,424 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.50% | 0.01% | 987,654 | - | - | 1,155,555 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 4,166 | 4,166 | 100.00% | 4,874 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 124,623 | - | - | 145,809 | Jun 30, 2024 |
MARSHALL WACE, LLP | 3.20% | 0.00% | 2,105,262 | - | - | 2,463,156 | Jun 30, 2024 |
XTX TOPCO LTD | 0.04% | 0.00% | 26,555 | 10,688 | 67.36% | 31,069 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 180,800 | 13,600 | 8.13% | 211,536 | Jun 30, 2024 |
MORGAN STANLEY | 2.99% | 0.00% | 1,972,343 | -224,891 | -10.24% | 2,307,641 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 2.51% | 0.00% | 1,651,515 | -192,670 | -10.45% | 1,932,273 | Jun 30, 2024 |
FMR LLC | 0.48% | - | 314,600 | - | - | 368,082 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 33,307 | - | - | 38,969 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 3,280 | 3,280 | 100.00% | 3,838 | Jun 30, 2024 |
STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -156,167 | -100.00% | - | Jun 30, 2024 |
The largest IO Biotech shareholder by % of total assets is SAMSARA BIOCAPITAL, LLC. The company owns 3.64M shares of IO Biotech (IOBT), representing 0.89% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.29% | 0.02% | 192,670 | 192,670 | 100.00% | 225,424 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 180,800 | 13,600 | 8.13% | 211,536 | Jun 30, 2024 |
XTX TOPCO LTD | 0.04% | 0.00% | 26,555 | 10,688 | 67.36% | 31,069 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 4,166 | 4,166 | 100.00% | 4,874 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 3,280 | 3,280 | 100.00% | 3,838 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 33,307 | - | - | 38,969 | Jun 30, 2024 |
FMR LLC | 0.48% | - | 314,600 | - | - | 368,082 | Jun 30, 2024 |
MARSHALL WACE, LLP | 3.20% | 0.00% | 2,105,262 | - | - | 2,463,156 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 124,623 | - | - | 145,809 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.50% | 0.01% | 987,654 | - | - | 1,155,555 | Jun 30, 2024 |
LOGOS GLOBAL MANAGEMENT LP | 0.75% | 0.05% | 493,827 | - | - | 577,778 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 3.55% | 0.14% | 2,341,107 | - | - | 2,739,095 | Jun 30, 2024 |
VIVO CAPITAL, LLC | 9.37% | 0.67% | 6,173,439 | - | - | 7,222,924 | Jun 30, 2024 |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.31% | 0.78% | 864,197 | - | - | 1,011,110 | Jun 30, 2024 |
SAMSARA BIOCAPITAL, LLC | 5.53% | 0.89% | 3,640,015 | - | - | 4,258,818 | Jun 30, 2024 |
STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -156,167 | -100.00% | - | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 2.35% | 0.02% | 1,545,000 | -179,000 | -10.38% | 1,807,650 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 2.51% | 0.00% | 1,651,515 | -192,670 | -10.45% | 1,932,273 | Jun 30, 2024 |
MORGAN STANLEY | 2.99% | 0.00% | 1,972,343 | -224,891 | -10.24% | 2,307,641 | Jun 30, 2024 |
NOVO HOLDINGS A/S | 6.72% | 0.30% | 4,429,449 | -658,809 | -12.95% | 5,182,455 | Jun 30, 2024 |
As of Jun 30 2024, IO Biotech's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 192.67K stocks of IOBT, valued at $225.42K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NOVO HOLDINGS A/S | 6.72% | 0.30% | 4,429,449 | -658,809 | -12.95% | 5,182,455 | Jun 30, 2024 |
MORGAN STANLEY | 2.99% | 0.00% | 1,972,343 | -224,891 | -10.24% | 2,307,641 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 2.51% | 0.00% | 1,651,515 | -192,670 | -10.45% | 1,932,273 | Jun 30, 2024 |
ARMISTICE CAPITAL, LLC | 2.35% | 0.02% | 1,545,000 | -179,000 | -10.38% | 1,807,650 | Jun 30, 2024 |
STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -156,167 | -100.00% | - | Jun 30, 2024 |
SAMSARA BIOCAPITAL, LLC | 5.53% | 0.89% | 3,640,015 | - | - | 4,258,818 | Jun 30, 2024 |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.31% | 0.78% | 864,197 | - | - | 1,011,110 | Jun 30, 2024 |
VIVO CAPITAL, LLC | 9.37% | 0.67% | 6,173,439 | - | - | 7,222,924 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 3.55% | 0.14% | 2,341,107 | - | - | 2,739,095 | Jun 30, 2024 |
LOGOS GLOBAL MANAGEMENT LP | 0.75% | 0.05% | 493,827 | - | - | 577,778 | Jun 30, 2024 |
ALYESKA INVESTMENT GROUP, L.P. | 1.50% | 0.01% | 987,654 | - | - | 1,155,555 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.19% | 0.00% | 124,623 | - | - | 145,809 | Jun 30, 2024 |
MARSHALL WACE, LLP | 3.20% | 0.00% | 2,105,262 | - | - | 2,463,156 | Jun 30, 2024 |
FMR LLC | 0.48% | - | 314,600 | - | - | 368,082 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.05% | - | 33,307 | - | - | 38,969 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 3,280 | 3,280 | 100.00% | 3,838 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 4,166 | 4,166 | 100.00% | 4,874 | Jun 30, 2024 |
XTX TOPCO LTD | 0.04% | 0.00% | 26,555 | 10,688 | 67.36% | 31,069 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 180,800 | 13,600 | 8.13% | 211,536 | Jun 30, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.29% | 0.02% | 192,670 | 192,670 | 100.00% | 225,424 | Jun 30, 2024 |
As of Jun 30 2024, IO Biotech's biggest institutional seller is NOVO HOLDINGS A/S. The company sold -0.66M shares of IOBT, valued at $5.18M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. | 0.29% | 0.02% | 192,670 | 192,670 | 100.00% | 225,424 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 4,166 | 4,166 | 100.00% | 4,874 | Jun 30, 2024 |
IO Biotech's largest new institutional shareholder by number of shares is SOLEUS CAPITAL MANAGEMENT, L.P., purchased 192.67K shares, valued at $225.42K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -156,167 | -100.00% | - | Jun 30, 2024 |
IO Biotech's largest sold out institutional shareholder by shares sold is STONEPINE CAPITAL MANAGEMENT, LLC, sold -0.16M shares, valued at -, as of undefined.
IO Biotech Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BRIDGEWAY FUNDS INC | 0.05% | 124,000 | -21,200 | -14.60% | Mar 28, 2024 |
SMALLCAP WORLD FUND INC | 0.01% | 419,714 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 40,174 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 62,234 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 25,040 | 12,310 | 96.70% | Feb 29, 2024 |
VICTORY PORTFOLIOS | 0.00% | 3,567 | - | - | Mar 31, 2024 |
IO Biotech's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 124.00K shares, compromising 0.05% of its total assets.
IO Biotech Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 3 | -83.33% |
31 Mar, 24 | 18 | -5.26% |
31 Dec, 23 | 19 | -5.00% |
30 Sep, 23 | 20 | 33.33% |
30 Jun, 23 | 15 | -11.76% |
31 Mar, 23 | 17 | - |
31 Dec, 22 | 17 | -15.00% |
30 Sep, 22 | 20 | 11.11% |
30 Jun, 22 | 18 | -5.26% |
31 Mar, 22 | 19 | -5.00% |
31 Dec, 21 | 20 | - |
As of 30 Jun 24, 3 institutions are holding IO Biotech's shares, representing a decrease of -83.33% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 218,273 | -99.20% |
31 Mar, 24 | 27,341,910 | -7.00% |
31 Dec, 23 | 29,400,721 | -0.90% |
30 Sep, 23 | 29,668,665 | 142.26% |
30 Jun, 23 | 12,246,779 | -12.00% |
31 Mar, 23 | 13,917,553 | -2.55% |
31 Dec, 22 | 14,281,285 | -6.87% |
30 Sep, 22 | 15,335,530 | -0.76% |
30 Jun, 22 | 15,453,557 | 4.00% |
31 Mar, 22 | 14,858,855 | -1.19% |
31 Dec, 21 | 15,038,466 | - |
IO Biotech (IOBT) has 218.27K shares outstanding as of 30 Jun 24, down -99.20% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 0.33% | 0.01% |
31 Mar, 24 | 62.80% | 1.83% |
31 Dec, 23 | 58.60% | 0.55% |
30 Sep, 23 | 102.96% | 5.70% |
30 Jun, 23 | 42.50% | 1.82% |
31 Mar, 23 | 48.30% | 1.97% |
31 Dec, 22 | 49.56% | 1.75% |
30 Sep, 22 | 53.22% | 1.85% |
30 Jun, 22 | 53.63% | 2.02% |
31 Mar, 22 | 51.57% | 1.51% |
31 Dec, 21 | 58.45% | - |
As of 30 Jun 24, IO Biotech is held by 0.33% institutional shareholders, representing a 0.01% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 2 | -60.00% |
31 Mar, 24 | 5 | -28.57% |
31 Dec, 23 | 7 | -41.67% |
30 Sep, 23 | 12 | 100.00% |
30 Jun, 23 | 6 | 50.00% |
31 Mar, 23 | 4 | - |
31 Dec, 22 | 4 | -50.00% |
30 Sep, 22 | 8 | - |
30 Jun, 22 | 8 | 33.33% |
31 Mar, 22 | 6 | -70.00% |
31 Dec, 21 | 20 | - |
2 institutional shareholders have increased their position in IOBT stock as of 30 Jun 24 compared to 5 in the previous quarter (a -60.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | -100.00% |
31 Mar, 24 | 5 | 25.00% |
31 Dec, 23 | 4 | 100.00% |
30 Sep, 23 | 2 | 100.00% |
30 Jun, 23 | 1 | -66.67% |
31 Mar, 23 | 3 | -40.00% |
31 Dec, 22 | 5 | 66.67% |
30 Sep, 22 | 3 | - |
30 Jun, 22 | 3 | 50.00% |
31 Mar, 22 | 2 | - |
31 Dec, 21 | - | - |
- institutional shareholders have reduced their position in IOBT stock as of 30 Jun 24 compared to 5 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 3 | -83.33% | 218,273 | -99.20% | 0.33% | 0.01% | 2 | -60.00% | - | -100.00% |
31 Mar, 24 | 18 | -5.26% | 27,341,910 | -7.00% | 62.80% | 1.83% | 5 | -28.57% | 5 | 25.00% |
31 Dec, 23 | 19 | -5.00% | 29,400,721 | -0.90% | 58.60% | 0.55% | 7 | -41.67% | 4 | 100.00% |
30 Sep, 23 | 20 | 33.33% | 29,668,665 | 142.26% | 102.96% | 5.70% | 12 | 100.00% | 2 | 100.00% |
30 Jun, 23 | 15 | -11.76% | 12,246,779 | -12.00% | 42.50% | 1.82% | 6 | 50.00% | 1 | -66.67% |
31 Mar, 23 | 17 | - | 13,917,553 | -2.55% | 48.30% | 1.97% | 4 | - | 3 | -40.00% |
31 Dec, 22 | 17 | -15.00% | 14,281,285 | -6.87% | 49.56% | 1.75% | 4 | -50.00% | 5 | 66.67% |
30 Sep, 22 | 20 | 11.11% | 15,335,530 | -0.76% | 53.22% | 1.85% | 8 | - | 3 | - |
30 Jun, 22 | 18 | -5.26% | 15,453,557 | 4.00% | 53.63% | 2.02% | 8 | 33.33% | 3 | 50.00% |
31 Mar, 22 | 19 | -5.00% | 14,858,855 | -1.19% | 51.57% | 1.51% | 6 | -70.00% | 2 | - |
31 Dec, 21 | 20 | - | 15,038,466 | - | 58.45% | - | 20 | - | - | - |
IO Biotech Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of IO Biotech's stock was made by Novo Holdings A/S on Jul 26 2024, selling 51,522 shares at $1.33 per share (valued at $68.34K). The last insider buy of IOBT was made by Burkavage Brian on Nov 24 2023, buying 5,000 shares at $1.03 per share (worth $5.17K).
IO Biotech Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 2 | - |
Q2 2024 | 6 | 1 | 600.00% |
Q1 2024 | 5 | 1 | 500.00% |
Q4 2023 | 3 | - | - |
Q3 2023 | 16 | - | - |
Q2 2023 | 5 | - | - |
Q1 2023 | 2 | - | - |
Q4 2022 | 1 | - | - |
Q2 2022 | 8 | 2 | 400.00% |
Q1 2022 | 1 | - | - |
Q4 2021 | 23 | 34 | 67.65% |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by IO Biotech's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 2 | - |
Q2 2024 | - | 1 | - |
Q1 2024 | - | 1 | - |
Q4 2023 | 2 | - | - |
Q3 2023 | 4 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | 1 | - | - |
Q4 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 8 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of IO Biotech's stocks.
IO Biotech Peer Ownership
Ticker | Company |
---|---|
PMVP | PMV Pharmaceuticals, Inc. |
CGEM | Cullinan Oncology, Inc. |
IVA | Inventiva S.A. |
IKNA | Ikena Oncology, Inc. |
STOK | Stoke Therapeutics, Inc. |
IPSC | Century Therapeutics, Inc. |
ERAS | Erasca, Inc. |
CSBR | Champions Oncology, Inc. |
ASLN | ASLAN Pharmaceuticals Limited |
GLUE | Monte Rosa Therapeutics, Inc. |
MNOV | MediciNova, Inc. |
DSGN | Design Therapeutics, Inc. |
PHVS | Pharvaris N.V. |
GPCR | Structure Therapeutics Inc. |
NAMS | NewAmsterdam Pharma Company N.V. |
HOWL | Werewolf Therapeutics, Inc. |
PEPG | PepGen Inc. |
LYRA | Lyra Therapeutics, Inc. |
PRDS | Pardes Biosciences, Inc. |
CMPX | Compass Therapeutics, Inc. |
STTK | Shattuck Labs, Inc. |
ELYM | Eliem Therapeutics, Inc. |
IOBT Ownership FAQ
Who Owns IO Biotech?
IO Biotech is owned by institutional shareholders (0.33%), insiders (0.24%), and public (99.43%). The largest institutional shareholder of IO Biotech is VIVO CAPITAL, LLC (9.37% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.05% of total shares).
Who are the major institutional shareholders of IO Biotech?
IO Biotech's major institutional shareholders are VIVO CAPITAL, LLC, NOVO HOLDINGS A/S, SAMSARA BIOCAPITAL, LLC, PFM HEALTH SCIENCES, LP, and MARSHALL WACE, LLP. The top five shareholders own together 28.37% of the company's share outstanding.
How many IO Biotech shareholders are there?
As of Jun 2024, there are 3 institutional shareholders of IO Biotech.
What percentage of IO Biotech is owned by VIVO CAPITAL, LLC?
VIVO CAPITAL, LLC owns 6.17M shares of IO Biotech, representing 9.37% of the company's total shares outstanding, valued at $7.22M (as of Jun 2024).
What percentage of IO Biotech is owned by NOVO HOLDINGS A/S?
As of Jun 2024, NOVO HOLDINGS A/S holds 4.43M shares of IO Biotech (IOBT), compromising 6.72% of the company, valued at $5.18M.
What percentage of IO Biotech is owned by SAMSARA BIOCAPITAL, LLC?
SAMSARA BIOCAPITAL, LLC is the third largest holder of IO Biotech. The company owns 3.64M of the company's shares outstanding (worth $4.26M).